David G. Tew

5.3k total citations · 2 hit papers
57 papers, 4.2k citations indexed

About

David G. Tew is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, David G. Tew has authored 57 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Cancer Research. Recurrent topics in David G. Tew's work include Protease and Inhibitor Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Electrochemical Analysis and Applications (4 papers). David G. Tew is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Electrochemical Analysis and Applications (4 papers). David G. Tew collaborates with scholars based in United Kingdom, United States and Spain. David G. Tew's co-authors include Valerie B. O’Donnell, Owen Jones, P. England, Christopher Southan, David J. Powell, P.R. Ortiz de Montellano, Thomas D. Meek, Colin H. Macphee, Israel Gloger and Helen Boyd and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

David G. Tew

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

1999 887 citations Ishrut Hussain, David J. Powell et al. Molecular and Cellular Neuroscience profile →
Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase

1993 518 citations David G. Tew et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David G. Tew United Kingdom	30	1.8k	1.2k	553	523	522	57	4.2k
Stephen J. Gardell United States	31	2.0k 1.1×	1.8k 1.4×	435 0.8×	505 1.0×	356 0.7×	84	4.4k
Abdul H. Fauq United States	45	3.0k 1.6×	1.3k 1.0×	251 0.5×	610 1.2×	356 0.7×	121	5.7k
Thomas D. Hurley United States	48	3.9k 2.2×	795 0.6×	421 0.8×	343 0.7×	1.1k 2.1×	114	7.2k
Umberto M. Marinari Italy	39	2.4k 1.3×	903 0.7×	225 0.4×	368 0.7×	573 1.1×	114	4.8k
Dolores Pérez‐Sala Spain	45	3.8k 2.1×	922 0.7×	754 1.4×	937 1.8×	693 1.3×	144	6.7k
W. Rodney Mathews United States	32	2.4k 1.3×	1.8k 1.5×	288 0.5×	609 1.2×	140 0.3×	63	4.7k
Cinzia Domenicotti Italy	33	2.3k 1.2×	574 0.5×	298 0.5×	305 0.6×	554 1.1×	106	4.1k
Yvonne Will United States	37	2.6k 1.4×	518 0.4×	307 0.6×	234 0.4×	321 0.6×	84	5.3k
Daniel D. Sternbach United States	27	3.7k 2.0×	1.1k 0.9×	530 1.0×	558 1.1×	518 1.0×	54	5.1k
Michel Gallant Canada	20	3.5k 1.9×	435 0.4×	226 0.4×	633 1.2×	460 0.9×	38	5.5k

Countries citing papers authored by David G. Tew

Since Specialization

Citations

This map shows the geographic impact of David G. Tew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Tew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Tew more than expected).

Fields of papers citing papers by David G. Tew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Tew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Tew. The network helps show where David G. Tew may publish in the future.

Co-authorship network of co-authors of David G. Tew

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Tew. A scholar is included among the top collaborators of David G. Tew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Tew. David G. Tew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dawson, William, Kathryn L. Shelley, Jordan M. Fletcher, et al.. (2023). Differential sensing with arrays of de novo designed peptide assemblies. Nature Communications. 14(1). 383–383. 24 indexed citations

Bell, David, et al.. (2020). Improved betulinic acid biosynthesis using synthetic yeast chromosome recombination and semi-automated rapid LC-MS screening. Nature Communications. 11(1). 868–868. 57 indexed citations

Ross, James F., Angela Bridges, Jordan M. Fletcher, et al.. (2017). Decorating Self-Assembled Peptide Cages with Proteins. ACS Nano. 11(8). 7901–7914. 52 indexed citations

Evans, Karen A., Frank T. Coppo, Todd L. Graybill, et al.. (2008). Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4068–4071. 9 indexed citations

Vázquez, María J., Stephen Ashman, Fernando Ramón, et al.. (2006). Utilization of Substrate-Induced Quenching for Screening Targets Promoting NADH and NADPH Consumption. SLAS DISCOVERY. 11(1). 75–81. 6 indexed citations

Demin, Oleg, David L. Earnshaw, Frank Tobin, et al.. (2006). The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high‐throughput screening. Biotechnology and Bioengineering. 95(4). 560–571. 17 indexed citations

Vázquez, María J., et al.. (2003). Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method. Analytical Biochemistry. 320(2). 292–298. 34 indexed citations

Paine, Mark J. I., Andrew P. Garner, David J. Powell, et al.. (2000). Cloning and Characterization of a Novel Human Dual Flavin Reductase. Journal of Biological Chemistry. 275(2). 1471–1478. 75 indexed citations

Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2000). N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(22). 2557–2561. 24 indexed citations

10.

Boyd, Helen, Robert J. Ife, Colin A. Leach, et al.. (2000). 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(4). 395–398. 17 indexed citations

11.

Hussain, Ishrut, David J. Powell, David Howlett, et al.. (2000). ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site. Molecular and Cellular Neuroscience. 16(5). 609–619. 131 indexed citations

12.

Benson, G. Martin, David C. Grimsditch, Kitty Moores, et al.. (2000). Anti-atherosclerotic effect of SB-244323, a lipoprotein associated phospholipase A2 inhibitor, in WHHL rabbits. Atherosclerosis. 151(1). 166–166. 12 indexed citations

13.

Zhao, Qiang, Sandeep Modi, Graeme C.M. Smith, et al.. (1999). Crystal structure of the FMN‐binding domain of human cytochrome P450 reductase at 1.93 Å resolution. Protein Science. 8(2). 298–306. 71 indexed citations

14.

Pinto, Ivan L., Richard L. Jarvest, Brian Clarke, et al.. (1999). Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism. Bioorganic & Medicinal Chemistry Letters. 9(3). 449–452. 28 indexed citations

15.

Garner, Andrew P., Mark J. I. Paine, Ignacio Rodríguez‐Crespo, et al.. (1999). Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents.. PubMed. 59(8). 1929–34. 95 indexed citations

16.

Dhanak, Dashyant, Richard M. Keenan, George Burton, et al.. (1998). Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease. Bioorganic & Medicinal Chemistry Letters. 8(24). 3677–3682. 42 indexed citations

17.

Bao, Yongping, Gary Williamson, David G. Tew, et al.. (1998). Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance. British Journal of Anaesthesia. 81(4). 584–589. 38 indexed citations

18.

Tatnell, Peter J., et al.. (1998). Napsins: new human aspartic proteinases. FEBS Letters. 441(1). 43–48. 63 indexed citations

19.

Zhao, Qiang, Graeme C.M. Smith, Sandeep Modi, et al.. (1996). Crystallization and Preliminary X-Ray Diffraction Studies of Human Cytochrome P450 Reductase. Journal of Structural Biology. 116(2). 320–325. 6 indexed citations

20.

Bell, Linda K., Joan Mason, D. Michael P. Mingos, & David G. Tew. (1983). Nitrogen-15 NMR studies of nitrosyl (bent and linear), nitro, and nitrito ligands in 4-, 5-, and 6-coordinate complexes of the platinum metals. Inorganic Chemistry. 22(24). 3497–3502. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact